Search

Your search keyword '"Fervenza, Fernando C"' showing total 1,256 results
Start Over Author "Fervenza, Fernando C"
1,256 results on '"Fervenza, Fernando C"'

252. Colaboradores

Author

Abbott, Jinnette Dawn, Agarwal, Rajiv, Al-Badri, Marwa, Ali, Hyeon-Ju Ryoo, Aliotta, Jason M., Almhanna, Khaldoun, Al-Qaisi, Mohanad T., Arzomand, Zuhal, Asombang, Akwi W., Aung, Su N., Azzoli, Christopher G., Bandera, Christina, Banerjee, Debasree, Batheja, Mashal, Bazarian, Jeffrey J., Benbadis, Selim R., Benjamin, Ivor J., Benoit, Eric, Berger, Marcie G., Bergwitz, Clemens, Berliner, Nancy, Berns, Jeffrey S., Bhadbhade, Pooja, Bhavaraju-Sanka, Ratna, Bichile, Tanmayee, Birnbaum, Ariel E., Bliss, Charles M., Jr., Blum, Andrew S., Bonder, Bryan J., Bratman, Russell, Braunstein, Glenn D., Bready, Alma M. Guerrero, Bungiro, Richard, Burgner, Anna Marie, Cahill, Jonathan, Canakis, Andrew, Carneiro, Benedito A., Casserly, Brian, Chahin, Abdullah, Chan, Philip A., Chapin, Kimberle, Cheshire, William P., Jr., Chung, Waihong, Ciafaloni, Emma, Cigarroa, Joaquin E., Cinquegrani, Michael P., Coca, Andreea, Cohen, Harvey Jay, Cohen, Scott, Concepcion, Beatrice P., Connell, Nathan T., Constantinou, Maria, Cortez, Roberto, Counihan, Timothy J., Cross, Anne Haney, Cunha, Cheston B., Cunha, Joanne S., Cu-Uvin, Susan, Dabbouseh, Noura M., Dapaah-Afriyie, Kwame, Denney-Koelsch, Erin M., De Souza, Andre, De Vriese, An S., Dharmadhikari, Neal D., Dickstein, Leah, Dizon, Don, Domsic, Robyn T., Eagle, Kim A., Earing, Michael G., Egan, Pamela, El-Deiry, Wafik S., Elkind, Mitchell S.V., Evans, Tarra B., Fallon, Michael B., Farmakiotis, Dimitrios, Farraye, Francis A., Farrell, Ronan, Fenton, Mary Anne, Fervenza, Fernando C., Fine, Sean, Finn, Arkadiy, Flanigan, Timothy, Flores, Brisas M., Foderaro, Andrew E., Friedman, Theodore C., Garland, Joseph Metmowlee, Gartman, Eric J., Geara, Abdallah, Gil, Raul Macias, Gilligan, Timothy, Goggins, Michael Raymond, Gopalakrishnan, Geetha, Gopinath, Vidya, Greenspan, Susan L., Hamdy, Osama, Hamel, Johanna, Handa, Sajeev, Heflin, Mitchell T., Holloway, Robert G., Huang, Christopher S., Hussain, Zilla, Ikizler, T. Alp, Isufi, Iris, Jackson, Carlayne E., Jacob, Paul G., Jankowich, Matthew D., Johnsen, Niels V., Johnson, Jessica E., June, Rayford R., Kheirbek, Tareq, Khorana, Alok A., Kilic, Sena, Kim, David, Kleczka, James, Klinger, James R., Koo, Patrick, Koolwal, Pooja, Kotlarczyk, Mary P., Kuderer, Nicole M., Kwara, Awewura, Kwon, Jennifer M., Lange, Richard A., Larkin, Jerome, Lee, Alfred I., Levine, Daniel J., Lewandowski, David E., Liang, Kelly V., Liang, Kimberly P., Lichtenstein, David R., Lienesch, Douglas W., Ling, Geoffrey S.F., Little, Ester, Liu, Yi, Lohr, Nicole L., Lonks, John R., Lyman, Gary H., Lyness, Jeffrey M., Lyons, Shane, Maas, Diana, Malik, Talha A., Manocha, Sonia, Manzi, Susan, Marshall, Frederick J., McCool, F. Dennis, McCulloh, Russell J., McGarry, Kelly, Govern, Eavan Mc, McKinney, Robin L., Mega, Anthony, Mehta, Shivang, Milam, Douglas F., Mileno, Maria D., Misra, Abhinav Kumar, Moe, Orson W., Mohan, Niveditha, Moreland, Larry W., Morrison, Alan R., Moss, Steven F., Mullin, Christopher J., Murphy, Sinéad M., Nallu, Sagarika, Neyra, Javier A., Noaiseh, Ghaith, Ollila, Thomas A., Opal, Steven M., Palmer, Biff F., Pan, Jen Jung, Papazoglou, Anna, Parnes, Aric, Patel, Nayan M., Pelcovits, Ari, Perazella, Mark A., Picco, Michael F., Powers, Kate E., Previll, Laura A., Rajora, Nilum, Ramirez-Zamora, Adolfo, Reagan, John, Reece, Rebecca, Rich, Harlan, Richman, Jennifer H., Rogers, Lisa R., Rogers, Ralph, Rose, Michal G., Roth, James A., Rounds, Sharon, Rubenstein, Jason C., Rupawala, Abbas, Sarvaideo, Jenna, Saxena, Ramesh, Schiffman, Fred J., Schneider, Ruth B., Seaborg, Kristin A., Seetharam, Anil, Seropian, Stuart, Sethi, Jigme Michael, Sethi, Sanjeev, Shane, Elizabeth, Sharma, Esseim, Shastri, Shani, Shea, Barry S., Shevell, Lauren, Smith, Joseph A., Jr., Smith, Robert J., Sohal, Davendra P.S., Song, Christopher, Sperry, Thomas, Statland, Jeffrey M., Stein, Emily M., Strande, Jennifer L., Strenger, Rochelle, Talbot, Thomas R., Tarolli, Christopher G., Tarshish, Yael, Taunk, Pushpak, Tsoukas, Philip, Tunkel, Allan R., Turner, Jeffrey M., Vazquez, Zoe G.S., Vela, Stacie A.F., Vespa, Paul M., Vongpatanasin, Wanpen, Walker, Marcella D., Wang, Eunice S., Wasan, Sharmeel K., Weber, Thomas J., Wilcoxson, Brandon J., Wing, Edward J., Wong, Ellice, Wysolmerski, John J., Yousefzai, Rayan, Ziegler, Thomas R., and Zon, Rebecca

Published
2022
Full Text
View/download PDF

253. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

Author

Fervenza, Fernando C., primary, Appel, Gerald B., additional, Barbour, Sean J., additional, Rovin, Brad H., additional, Lafayette, Richard A., additional, Aslam, Nabeel, additional, Jefferson, Jonathan A., additional, Gipson, Patrick E., additional, Rizk, Dana V., additional, Sedor, John R., additional, Simon, James F., additional, McCarthy, Ellen T., additional, Brenchley, Paul, additional, Sethi, Sanjeev, additional, Avila-Casado, Carmen, additional, Beanlands, Heather, additional, Lieske, John C., additional, Philibert, David, additional, Li, Tingting, additional, Thomas, Leslie F., additional, Green, Dolly F., additional, Juncos, Luis A., additional, Beara-Lasic, Lada, additional, Blumenthal, Samuel S., additional, Sussman, Amy N., additional, Erickson, Stephen B., additional, Hladunewich, Michelle, additional, Canetta, Pietro A., additional, Hebert, Lee A., additional, Leung, Nelson, additional, Radhakrishnan, Jay, additional, Reich, Heather N., additional, Parikh, Samir V., additional, Gipson, Debbie S., additional, Lee, Dominic K., additional, da Costa, Bruno R., additional, Jüni, Peter, additional, and Cattran, Daniel C., additional

Published
2019
Full Text
View/download PDF

254. Standardized Outcomes in Nephrology—Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease

Author

Carter, Simon A., primary, Lightstone, Liz, additional, Cattran, Daniel, additional, Bagga, Arvind, additional, Barbour, Sean J., additional, Barratt, Jonathan, additional, Boletis, John, additional, Caster, Dawn, additional, Coppo, Rosanna, additional, Fervenza, Fernando C., additional, Floege, Jürgen, additional, Hladunewich, Michelle, additional, Hogan, Jonathan J., additional, Kitching, A. Richard, additional, Lafayette, Richard, additional, Malvar, Ana, additional, Radhakrishnan, Jai, additional, Rovin, Brad H., additional, Zhang, Hong, additional, Gutman, Talia, additional, Howell, Martin, additional, Logeman, Charlotte, additional, Shen, Jenny I., additional, Teixeira-Pinto, Armando, additional, Alexander, Stephen I., additional, Cho, Yeoungjee, additional, Craig, Jonathan C., additional, Harris, David, additional, Johnson, David W., additional, Kerr, Peter G., additional, Ryan, Jessica, additional, Viecelli, Andrea K., additional, Wang, Angela Yee-Moon, additional, Wilkie, Martin, additional, Scholes-Robertson, Nicole, additional, and Tong, Allison, additional

Published
2019
Full Text
View/download PDF

255. Exostosin 1/Exostosin 2–Associated Membranous Nephropathy

Author

Sethi, Sanjeev, primary, Madden, Benjamin J., additional, Debiec, Hanna, additional, Charlesworth, M. Cristine, additional, Gross, LouAnn, additional, Ravindran, Aishwarya, additional, Hummel, Amber M., additional, Specks, Ulrich, additional, Fervenza, Fernando C., additional, and Ronco, Pierre, additional

Published
2019
Full Text
View/download PDF

256. Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients

Author

Nasr, Samih H., primary, Dasari, Surendra, additional, Lieske, John C., additional, Benson, Linda M., additional, Vanderboom, Patrick M., additional, Holtz-Heppelmann, Carrie J., additional, Giesen, Callen D., additional, Snyder, Melissa R., additional, Erickson, Stephen B., additional, Fervenza, Fernando C., additional, Leung, Nelson, additional, Kurtin, Paul J., additional, and Alexander, Mariam P., additional

Published
2019
Full Text
View/download PDF

257. Health-related quality of life in glomerular disease

Author

Canetta, Pietro A., primary, Troost, Jonathan P., additional, Mahoney, Shannon, additional, Kogon, Amy J., additional, Carlozzi, Noelle, additional, Bartosh, Sharon M., additional, Cai, Yi, additional, Davis, T. Keefe, additional, Fernandez, Hilda, additional, Fornoni, Alessia, additional, Gbadegesin, Rasheed A., additional, Herreshoff, Emily, additional, Mahan, John D., additional, Nachman, Patrick H., additional, Selewski, David T., additional, Sethna, Christine B., additional, Srivastava, Tarak, additional, Tuttle, Katherine R., additional, Wang, Chia-shi, additional, Falk, Ronald J., additional, Gharavi, Ali G., additional, Gillespie, Brenda W., additional, Greenbaum, Larry A., additional, Holzman, Lawrence B., additional, Kretzler, Matthias, additional, Robinson, Bruce M., additional, Smoyer, William E., additional, Guay-Woodford, Lisa M., additional, Reeve, Bryce, additional, Gipson, Debbie S., additional, Ahn, Wooin, additional, Appel, Gerald B., additional, Babayev, Revekka, additional, Batal, Ibrahim, additional, Bomback, Andrew S., additional, Brown, Eric, additional, Campenot, Eric S., additional, Canetta, Pietro, additional, Carlassara, Lucrezia, additional, Chan, Brenda, additional, Chatterjee, Debanjana, additional, D’Agati, Vivette D., additional, Delbarba, Elisa, additional, Dogra, Samriti, additional, Foroncewicz, Bartosz, additional, Ghiggeri, Gian Marco, additional, Hines, William H., additional, Husain, S. Ali, additional, Jain, Namrata G., additional, Khairallah, Pascale, additional, Kil, Byum Hee, additional, Kiryluk, Krzysztof, additional, Jeyabalan, Anushya, additional, Lau, Wai L., additional, Lin, Fangming, additional, Lugani, Francesca, additional, Marasa, Maddalena, additional, Markowitz, Glen, additional, Mohan, Sumit, additional, Mu, Xueru, additional, Mucha, Krzysztof, additional, Nickolas, Thomas L., additional, Piva, Stacy, additional, Radhakrishnan, Jai, additional, Rao, Maya K., additional, Renu, Regunathan-Shenk, additional, Sanna-Cherchi, Simone, additional, Santoriello, Dominick, additional, Shirazian, Shayan, additional, Stokes, Michael B., additional, Uy, Natalie, additional, Valeri, Anthony M., additional, Al-Uzri, Amira, additional, Ambruzs, Josephine, additional, Ashoor, Isa, additional, Aviles, Diego, additional, Baracco, Rossana, additional, Barcia, John, additional, Bartosh, Sharon, additional, Belsha, Craig, additional, Bowers, Corinna, additional, Braun, Michael C., additional, Chernitskiy, Vladimir, additional, Chishti, Aftab, additional, Claes, Donna, additional, Clark, Kira, additional, Cramer, Carl, additional, Davis, Keefe, additional, Erkan, Elif, additional, Feig, Daniel, additional, Freundlich, Michael, additional, Gaut, Joseph, additional, Gbadegesin, Rasheed, additional, Hanna, Melisha, additional, Hidalgo, Guillermo, additional, Hooper, David, additional, Hunley, Tracy E., additional, Jain, Amrish, additional, Kallash, Mahmoud, additional, Kamel, Margo, additional, Khalid, Myda, additional, Klein, Jon B., additional, Kump, Theresa, additional, Lane, Jerome C., additional, Liapis, Helen, additional, Mahan, John, additional, Nester, Carla, additional, Pan, Cynthia, additional, Patterson, Larry, additional, Patel, Hiren, additional, Raad, Alice, additional, Revell, Adelaide, additional, Rheault, Michelle N., additional, Silva, Cynthia, additional, Sreedharan, Rajasree, additional, Steinke, Julia, additional, Sumner, Susan, additional, Twombley, Katherine, additional, Wenderfer, Scott E., additional, Vasylyeva, Tetyana L., additional, Weaver, Donald J., additional, Wong, Craig S., additional, Yin, Hong, additional, Achanti, Anand, additional, Almaani, Salem, additional, Ayoub, Isabelle, additional, Budisavljevic, Milos, additional, D’Angelo, Maggie, additional, Fatima, Huma, additional, Falk, Ronald, additional, Fogo, Agnes, additional, Gibson, Keisha, additional, Glenn, Dorey, additional, Hogan, Susan, additional, Jennette, J. Charles, additional, Julian, Bruce, additional, Kidd, Jason, additional, Laurin, Louis-Philippe, additional, Massey, H. Davis, additional, Mottl, Amy, additional, Murphy, Shannon, additional, Nachman, Patrick, additional, Nadasdy, Tibor, additional, Novak, Jan, additional, Parikh, Samir, additional, Poulton, Caroline, additional, Powell, Thomas Brian, additional, Renfrow, Matthew, additional, Reynolds, Monica, additional, Rizk, Dana, additional, Rovin, Brad, additional, Royal, Virginie, additional, Sanghani, Neil, additional, Self, Sally, additional, Adler, Sharon, additional, Alachkar, Nada, additional, Alpers, Charles, additional, Matar, Raed Bou, additional, Avila-Casado, Carmen, additional, Bagnasco, Serena, additional, Brede, Emily, additional, Brown, Elizabeth, additional, Cattran, Daniel, additional, Choi, Michael, additional, Dell, Katherine M., additional, Dewalt, Darren, additional, Denburg, Michelle, additional, Dukkipati, Ram, additional, Fervenza, Fernando C., additional, Gadegbeku, Crystal, additional, Gipson, Patrick, additional, Gonzalez-Zea, Anny, additional, Hasely, Leah, additional, Hendren, Elizabeth, additional, Hingorani, Sangeeta, additional, Hladunewich, Michelle, additional, Hogan, Jonathan, additional, Hou, Jean, additional, Jefferson, J. Ashley, additional, Jhaveri, Kenar, additional, Johnstone, Duncan B., additional, Kaskel, Frederick, additional, Kogan, Amy, additional, Kopp, Jeffrey, additional, Lafayette, Richard, additional, Lemley, Kevin V., additional, Malaga-Dieguez, Laura, additional, Meyers, Kevin, additional, Neu, Alicia, additional, O'Shaughnessy, Michelle Marie, additional, O’Toole, John F., additional, Oliverio, Andrea, additional, Palmer, Matthew, additional, Parekh, Rulan, additional, Pitter, Renee, additional, Reich, Heather, additional, Reidy, Kimberly, additional, Rondon, Helbert, additional, Sambandam, Kamalanathan K., additional, Sampson, Matthew, additional, Sedor, John R., additional, Schelling, Jeffrey, additional, Sperati, John C., additional, Swiatecka-Urban, Agnes, additional, Trachtman, Howard, additional, Waldman, Meryl, additional, Weisstuch, Joseph, additional, Wiggins, Roger, additional, Williams, David, additional, Winkler, Cheryl, additional, Vento, Suzanne, additional, Young, Eric, additional, Zhdanova, Olga, additional, Barisoni, Laura, additional, Beil, Charlotte, additional, Eikstadt, Richard, additional, Gillespie, Brenda, additional, Graff, John, additional, Hewitt, Stephen, additional, Hill-Callahan, Peg, additional, Helmuth, Margaret, additional, Lienczewski, Chrysta, additional, Mansfield, Sarah, additional, Mariani, Laura, additional, McCullough, Keith, additional, Moore, Nicholas, additional, Nast, Cynthia C., additional, Sexton, Melissa, additional, Troost, Jonathan, additional, Wladkowski, Matthew, additional, Zee, Jarcy, additional, and Zinsser, Dawn, additional

Published
2019
Full Text
View/download PDF

261. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease

Author

Mariani, Laura H., primary, Bomback, Andrew S., additional, Canetta, Pietro A., additional, Flessner, Michael F., additional, Helmuth, Margaret, additional, Hladunewich, Michelle A., additional, Hogan, Jonathan J., additional, Kiryluk, Krzysztof, additional, Nachman, Patrick H., additional, Nast, Cynthia C., additional, Rheault, Michelle N., additional, Rizk, Dana V., additional, Trachtman, Howard, additional, Wenderfer, Scott E., additional, Bowers, Corinna, additional, Hill-Callahan, Peg, additional, Marasa, Maddalena, additional, Poulton, Caroline J., additional, Revell, Adelaide, additional, Vento, Suzanne, additional, Barisoni, Laura, additional, Cattran, Dan, additional, D’Agati, Vivette, additional, Jennette, J. Charles, additional, Klein, Jon B., additional, Laurin, Louis-Philippe, additional, Twombley, Katherine, additional, Falk, Ronald J., additional, Gharavi, Ali G., additional, Gillespie, Brenda W., additional, Gipson, Debbie S., additional, Greenbaum, Larry A., additional, Holzman, Lawrence B., additional, Kretzler, Matthias, additional, Robinson, Bruce, additional, Smoyer, William E., additional, Guay-Woodford, Lisa M., additional, Ahn, Wooin, additional, Appel, Gerald B., additional, Babayev, Revekka, additional, Batal, Ibrahim, additional, Brown, Eric, additional, Campenot, Eric S., additional, Canetta, Pietro, additional, Carlassara, Lucrezia, additional, Chan, Brenda, additional, Chatterjee, Debanjana, additional, D’Agati, Vivette D., additional, Delbarba, Elisa, additional, Dogra, Samriti, additional, Fernandez, Hilda, additional, Foroncewicz, Bartosz, additional, Ghiggeri, Gian Marco, additional, Hines, William H., additional, Ali Husain, S., additional, Jain, Namrata G., additional, Khairallah, Pascale, additional, Kil, Byum Hee, additional, Jeyabalan, Anushya, additional, Lau, Wai L., additional, Lin, Fangming, additional, Lugani, Francesca, additional, Markowitz, Glen, additional, Mohan, Sumit, additional, Mu, Xueru, additional, Mucha, Krzysztof, additional, Nickolas, Thomas L., additional, Piva, Stacy, additional, Radhakrishnan, Jai, additional, Rao, Maya K., additional, Regunathan-Shenk, Renu, additional, Sanna-Cherchi, Simone, additional, Santoriello, Dominick, additional, Shirazian, Shayan, additional, Stokes, Michael B., additional, Yu, Natalie, additional, Valeri, Anthony M., additional, Zviti, Ronald, additional, Al-Uzri, Amira, additional, Ambruzs, Josephine, additional, Ashoor, Isa, additional, Aviles, Diego, additional, Baracco, Rossana, additional, Barcia, John, additional, Bartosh, Sharon, additional, Belsha, Craig, additional, Braun, Michael C., additional, Cai, Yi, additional, Chernitskiy, Vladimir, additional, Chishti, Aftab, additional, Claes, Donna, additional, Clark, Kira, additional, Cramer, Carl, additional, Davis, Keefe, additional, Dutcher, Amy, additional, Erkan, Elif, additional, Feig, Daniel, additional, Freundlich, Michael, additional, Gaut, Joseph, additional, Gbadegesin, Rasheed, additional, Hanna, Melisha, additional, Hidalgo, Guillermo, additional, Hooper, David, additional, Hunley, Tracy E., additional, Jain, Amrish, additional, Kallash, Mahmoud, additional, Kamel, Margo, additional, Khalid, Myda, additional, Kump, Theresa, additional, Lane, Jerome C., additional, Liapis, Helen, additional, Mahan, John, additional, Mathews, Nisha, additional, Nester, Carla, additional, Pan, Cynthia, additional, Patterson, Larry, additional, Patel, Hiren, additional, Raad, Alice, additional, Silva, Cynthia, additional, Sreedharan, Rajasree, additional, Srivastava, Tarak, additional, Steinke, Julia, additional, Sumner, Susan, additional, Vasylyeva, Tetyana L., additional, Wang, Chia-shi, additional, Weaver, Donald J., additional, Wong, Craig S., additional, Yin, Hong, additional, Achanti, Anand, additional, Almaani, Salem, additional, Ayoub, Isabelle, additional, Budisavljevic, Milos, additional, D'Angelo, Maggie, additional, Derebail, Vimal, additional, Fatima, Huma, additional, Falk, Ronald, additional, Fogo, Agnes, additional, Gibson, Keisha, additional, Glenn, Dorey, additional, Hogan, Susan, additional, Jain, Koyal, additional, Julian, Bruce, additional, Kidd, Jason, additional, Massey, H. Davis, additional, Mottl, Amy, additional, Murphy, Shannon, additional, Nadasdy, Tibor, additional, Novak, Jan, additional, Parikh, Samir, additional, Poulton, Caroline, additional, Powell, Thomas Brian, additional, Reeve, Bryce, additional, Renfrow, Matthew, additional, Reynolds, Monica, additional, Rizk, Dana, additional, Rovin, Brad, additional, Royal, Virginie, additional, Saha, Manish, additional, Sanghani, Neil, additional, Self, Sally, additional, Adler, Sharon, additional, Alachkar, Nada, additional, Alpers, Charles, additional, Matar, Raed Bou, additional, Avila-Casado, Carmen, additional, Bagnasco, Serena, additional, Brede, Emily, additional, Brown, Elizabeth, additional, Cattran, Daniel, additional, Choi, Michael, additional, Contreras, Gabriel, additional, Dell, Katherine M., additional, Dewalt, Darren, additional, Denburg, Michelle, additional, Dukkipati, Ram, additional, Fervenza, Fernando C., additional, Fornoni, Alessia, additional, Gadegbeku, Crystal, additional, Gipson, Patrick, additional, Gonzalez-Zea, Anny, additional, Hasely, Leah, additional, Hendren, Elizabeth, additional, Hingorani, Sangeeta, additional, Hladunewich, Michelle, additional, Hogan, Jonathan, additional, Hou, Jean, additional, Jefferson, J. Ashley, additional, Jhaveri, Kenar, additional, Johnstone, Duncan B., additional, Kaskel, Frederick, additional, Kogan, Amy, additional, Kopp, Jeffrey, additional, Lafayette, Richard, additional, Lemley, Kevin V., additional, Malaga-Dieguez, Laura, additional, Meyers, Kevin, additional, Neu, Alicia, additional, O'Shaughnessy, Michelle Marie, additional, O’Toole, John F., additional, Oliverio, Andrea, additional, Palmer, Matthew, additional, Parekh, Rulan, additional, Pitter, Renee, additional, Reich, Heather, additional, Reidy, Kimberly, additional, Rondon, Helbert, additional, Sambandam, Kamalanathan K., additional, Sampson, Matthew, additional, Sedor, John R., additional, Selewski, David T., additional, Sethna, Christine B., additional, Schelling, Jeffrey, additional, Sperati, John C., additional, Swiatecka-Urban, Agnes, additional, Tuttle, Katherine R., additional, Waldman, Meryl, additional, Weisstuch, Joseph, additional, Wiggins, Roger, additional, Williams, David, additional, Winkler, Cheryl, additional, Young, Eric, additional, Zhdanova, Olga, additional, Beil, Charlotte, additional, Eikstadt, Richard, additional, Gillespie, Brenda, additional, Graff, John, additional, Hewitt, Stephen, additional, Herreshoff, Emily, additional, Lienczewski, Chrysta, additional, Mansfield, Sarah, additional, Mariani, Laura, additional, McCullough, Keith, additional, Moore, Nicholas, additional, Robinson, Bruce M., additional, Sexton, Melissa, additional, Troost, Jonathan, additional, Wladkowski, Matthew, additional, Zee, Jarcy, additional, and Zinsser, Dawn, additional

Published
2019
Full Text
View/download PDF

262. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Author

Rovin, Brad H., primary, Caster, Dawn J., additional, Cattran, Daniel C., additional, Gibson, Keisha L., additional, Hogan, Jonathan J., additional, Moeller, Marcus J., additional, Roccatello, Dario, additional, Cheung, Michael, additional, Wheeler, David C., additional, Winkelmayer, Wolfgang C., additional, Floege, Jürgen, additional, Adler, Sharon G., additional, Alpers, Charles E., additional, Ayoub, Isabelle, additional, Bagga, Arvind, additional, Barbour, Sean J., additional, Barratt, Jonathan, additional, Chan, Daniel T.M., additional, Chang, Anthony, additional, Choo, Jason Chon Jun, additional, Cook, H. Terence, additional, Coppo, Rosanna, additional, Fervenza, Fernando C., additional, Fogo, Agnes B., additional, Fox, Jonathan G., additional, Glassock, Richard J., additional, Harris, David, additional, Hodson, Elisabeth M., additional, Hoxha, Elion, additional, Iseki, Kunitoshi, additional, Jennette, J. Charles, additional, Jha, Vivekanand, additional, Johnson, David W., additional, Kaname, Shinya, additional, Katafuchi, Ritsuko, additional, Kitching, A. Richard, additional, Lafayette, Richard A., additional, Li, Philip K.T., additional, Liew, Adrian, additional, Lv, Jicheng, additional, Malvar, Ana, additional, Maruyama, Shoichi, additional, Mejía-Vilet, Juan Manuel, additional, Mok, Chi Chiu, additional, Nachman, Patrick H., additional, Nester, Carla M., additional, Noiri, Eisei, additional, O'Shaughnessy, Michelle M., additional, Özen, Seza, additional, Parikh, Samir M., additional, Park, Hyeong-Cheon, additional, Peh, Chen Au, additional, Pendergraft, William F., additional, Pickering, Matthew C., additional, Pillebout, Evangéline, additional, Radhakrishnan, Jai, additional, Rathi, Manish, additional, Ronco, Pierre, additional, Smoyer, William E., additional, Tang, Sydney C.W., additional, Tesař, Vladimír, additional, Thurman, Joshua M., additional, Trimarchi, Hernán, additional, Vivarelli, Marina, additional, Walters, Giles D., additional, Wang, Angela Yee-Moon, additional, Wenderfer, Scott E., additional, and Wetzels, Jack F.M., additional

Published
2019
Full Text
View/download PDF

263. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Author

Floege, Jürgen, primary, Barbour, Sean J., additional, Cattran, Daniel C., additional, Hogan, Jonathan J., additional, Nachman, Patrick H., additional, Tang, Sydney C.W., additional, Wetzels, Jack F.M., additional, Cheung, Michael, additional, Wheeler, David C., additional, Winkelmayer, Wolfgang C., additional, Rovin, Brad H., additional, Adler, Sharon G., additional, Alpers, Charles E., additional, Ayoub, Isabelle, additional, Bagga, Arvind, additional, Barratt, Jonathan, additional, Caster, Dawn J., additional, Chan, Daniel T.M., additional, Chang, Anthony, additional, Choo, Jason Chon Jun, additional, Cook, H. Terence, additional, Coppo, Rosanna, additional, Fervenza, Fernando C., additional, Fogo, Agnes B., additional, Fox, Jonathan G., additional, Gibson, Keisha L., additional, Glassock, Richard J., additional, Harris, David, additional, Hodson, Elisabeth M., additional, Hoxha, Elion, additional, Iseki, Kunitoshi, additional, Jennette, J. Charles, additional, Jha, Vivekanand, additional, Johnson, David W., additional, Kaname, Shinya, additional, Katafuchi, Ritsuko, additional, Kitching, A. Richard, additional, Lafayette, Richard A., additional, Li, Philip K.T., additional, Liew, Adrian, additional, Lv, Jicheng, additional, Malvar, Ana, additional, Maruyama, Shoichi, additional, Mejía-Vilet, Juan Manuel, additional, Moeller, Marcus J., additional, Mok, Chi Chiu, additional, Nester, Carla M., additional, Noiri, Eisei, additional, O'Shaughnessy, Michelle M., additional, Özen, Seza, additional, Parikh, Samir M., additional, Park, Hyeong-Cheon, additional, Peh, Chen Au, additional, Pendergraft, William F., additional, Pickering, Matthew C., additional, Pillebout, Evangéline, additional, Radhakrishnan, Jai, additional, Rathi, Manish, additional, Roccatello, Dario, additional, Ronco, Pierre, additional, Smoyer, William E., additional, Tesař, Vladimír, additional, Thurman, Joshua M., additional, Trimarchi, Hernán, additional, Vivarelli, Marina, additional, Walters, Giles D., additional, Wang, Angela Yee-Moon, additional, and Wenderfer, Scott E., additional

Published
2019
Full Text
View/download PDF

264. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

Author

Heerspink, Hiddo J L, primary, Greene, Tom, additional, Tighiouart, Hocine, additional, Gansevoort, Ron T, additional, Coresh, Josef, additional, Simon, Andrew L, additional, Chan, Tak Mao, additional, Hou, Fan Fan, additional, Lewis, Julia B, additional, Locatelli, Francesco, additional, Praga, Manuel, additional, Schena, Francesco Paolo, additional, Levey, Andrew S, additional, Inker, Lesley A, additional, Sevillano, Angel, additional, Kamper, Anne-Lise, additional, van Zuilen, Arjan D., additional, Brenner, Barry M., additional, Maes, Bart, additional, Ihle, Benno U., additional, Barret, Brendan, additional, Leung, CB, additional, Szeto, CC, additional, Fitzner, Christina, additional, Wanner, Christoph, additional, Pozzi, Claudio, additional, Montagnino, Claudio Ponticelli, additional, Xie, Di, additional, de Zeeuw, Dick, additional, Lewis, Edmund, additional, Verde, Eduardo, additional, Gutierrez, Eduardo, additional, Imai, Enyu, additional, Caravaca, Fernando, additional, Fervenza, Fernando C., additional, Kobayashi, Fumiaki, additional, Moroni, Gabriella, additional, Becker, Gavin J., additional, Beck, Gerald J., additional, Appel, Gerald B., additional, Frisch, Gershon, additional, van Essen, GG, additional, Maschio, Giuseppe, additional, Remuzzi, Giuseppe, additional, Montogrino, Giuseppe, additional, Parving, Hans-Henrik, additional, Heerspink, Hiddo J.L., additional, Makino, Hirofumi, additional, Jehan, Imitiaz, additional, Wetzels, Jack F.M., additional, Donadio, James, additional, Dwyer, Jamie, additional, van den Brand, Jan, additional, Kusek, John, additional, Lachin, John M., additional, Luño, Jose, additional, Lewis, Julia B., additional, Floege, Jürgen, additional, Abebe, Kaleab Z., additional, Chow, KM, additional, Hunsicker, Lawrence G., additional, del Vecchio, Lucia, additional, Carlo, Manno, additional, Goicoechea, Marian, additional, von Eynatten, Maximilian, additional, Poulter, Neil, additional, Chaturvedi, Nish, additional, Passerini, Patrizia, additional, de Jong, Paul E., additional, Blankestijn, Peter J., additional, Li, Philip, additional, Ruggenenti, Piero, additional, Zucchelli, Pietro, additional, Kincaid-Smith, Priscilla S., additional, Hilgers, Ralf-Dieter, additional, Estacio, Raymond O., additional, Rohde, Richard D., additional, Katafuchi, Ritsuko, additional, Toto, Robert D., additional, Schrier, Robert W., additional, Rodby, Roger A., additional, Perrone, Ronald D., additional, Ito, Sadayoshi, additional, Klahr, Saulo, additional, Andrulli, Simeone, additional, Strandgaard, Svend, additional, Hannedouche, Thierry P., additional, Rauen, Thomas, additional, Verdalles, Ursula, additional, Perkovic, Vlado, additional, and Keane, William, additional

Published
2019
Full Text
View/download PDF

267. Open-Label Clinical Trials of Oral Pulse Dexamethasone for Adults with Idiopathic Nephrotic Syndrome

Author

Cho, Monique E., primary, Branton, Mary H., additional, Smith, David A., additional, Bartlett, Linda, additional, Howard, Lilian, additional, Reynolds, James C., additional, Rosenstein, Donald, additional, Sethi, Sanjeev, additional, Nava, M. Berenice, additional, Barisoni, Laura, additional, Fervenza, Fernando C., additional, and Kopp, Jeffrey B., additional

Published
2019
Full Text
View/download PDF

268. Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression

Author

Neuen, Brendon L., Tighiouart, Hocine, Heerspink, Hiddo J.L., Vonesh, Edward F., Chaudhari, Juhi, Miao, Shiyuan, Chan, Tak Mao, Fervenza, Fernando C., Floege, J?rgen, Goicoechea, Marian, Herrington, William G., Imai, Enyu, Jafar, Tazeen H., Lewis, Julia B., Li, Philip Kam-Tao, Locatelli, Francesco, Maes, Bart D., Perrone, Ronald D., Praga, Manuel, Perna, Annalisa, Schena, Francesco P., Wanner, Christoph, Wetzels, Jack F.M., Woodward, Mark, Xie, Di, Greene, Tom, and Inker, Lesley A.

Abstract

GFR slope has been proposed as a surrogate endpoint for progression to kidney failure in clinical trials studying patients with CKD. Acute or immediate effects on GFR after treatment initiation may complicate the interpretation of long-term treatment effects. In this large meta-analysis of 53 randomized clinical studies of CKD progression, the authors found the magnitude and nature of acute effects are variable across different interventions and may be larger at a higher baseline GFR. Negative acute effects (such as an acute reduction in GFR) were observed in trials of renin-angiotensin system blockade and BP lowering, whereas positive acute effects were more common in trials of immunosuppressive therapies. Such information can inform the optimal design and analysis plan for randomized clinical trials in CKD.

Published
2022
Full Text
View/download PDF

269. Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

Author

Leung, Nelson, primary, Bridoux, Frank, additional, Batuman, Vecihi, additional, Chaidos, Aristeidis, additional, Cockwell, Paul, additional, D’Agati, Vivette D., additional, Dispenzieri, Angela, additional, Fervenza, Fernando C., additional, Fermand, Jean- Paul, additional, Gibbs, Simon, additional, Gillmore, Julian D., additional, Herrera, Guillermo A., additional, Jaccard, Arnaud, additional, Jevremovic, Dragan, additional, Kastritis, Efstathios, additional, Kukreti, Vishal, additional, Kyle, Robert A., additional, Lachmann, Helen J., additional, Larsen, Christopher P., additional, Ludwig, Heinz, additional, Markowitz, Glen S., additional, Merlini, Giampaolo, additional, Mollee, Peter, additional, Picken, Maria M., additional, Rajkumar, Vincent S., additional, Royal, Virginie, additional, Sanders, Paul W., additional, Sethi, Sanjeev, additional, Venner, Christopher P., additional, Voorhees, Peter M., additional, Wechalekar, Ashutosh D., additional, Weiss, Brendan M., additional, and Nasr, Samih H., additional

Published
2018
Full Text
View/download PDF

270. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

Author

Leung, Nelson, primary, Bridoux, Frank, additional, Batuman, Vecihi, additional, Chaidos, Aristeidis, additional, Cockwell, Paul, additional, D’Agati, Vivette D., additional, Dispenzieri, Angela, additional, Fervenza, Fernando C., additional, Fermand, Jean-Paul, additional, Gibbs, Simon, additional, Gillmore, Julian D., additional, Herrera, Guillermo A., additional, Jaccard, Arnaud, additional, Jevremovic, Dragan, additional, Kastritis, Efstathios, additional, Kukreti, Vishal, additional, Kyle, Robert A., additional, Lachmann, Helen J., additional, Larsen, Christopher P., additional, Ludwig, Heinz, additional, Markowitz, Glen S., additional, Merlini, Giampaolo, additional, Mollee, Peter, additional, Picken, Maria M., additional, Rajkumar, Vincent S., additional, Royal, Virginie, additional, Sanders, Paul W., additional, Sethi, Sanjeev, additional, Venner, Christopher P., additional, Voorhees, Peter M., additional, Wechalekar, Ashutosh D., additional, Weiss, Brendan M., additional, and Nasr, Samih H., additional

Published
2018
Full Text
View/download PDF

274. The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy.

Author

Bobart, Shane A, Alexander, Mariam P, Shawwa, Khaled, Vaughan, Lisa E, Ghamrawi, Ranine, Sethi, Sanjeev, Cornell, Lynn, Glassock, Richard J, Fervenza, Fernando C, and Zand, Ladan

Subjects
IGA glomerulonephritis, HEMATURIA, EPIDERMAL growth factor receptors, ERYTHROCYTES, GLOMERULAR filtration rate
Abstract

Background Microhematuria is common in immunoglobulin A nephropathy (IgAN). However, current prognostication is based on proteinuria and mesangial hypercellularity, endocapillary hypercellularity, segmental sclerosis, tubulointerstitial fibrosis and crescent (MEST-C) scores. Methods In this retrospective study, we evaluated whether MEST-C score components are associated with the presence of microhematuria at biopsy and whether the degree of microhematuria during follow-up is associated with change in estimated glomerular filtration rate (eGFR), after adjusting for clinical and histological parameters. We identified 125 patients with biopsy-proven IgAN and MEST-C scoring who were not on immunosuppressive therapy at biopsy. Microhematuria was defined as ≥3 red blood cells (RBCs)/high-power field (hpf). Results Of the 125 patients, 97 had microhematuria at baseline and were more likely to have M1, E1 and C ≥ 1 lesions (P < 0.05 for all) compared with patients without microhematuria. Of the 125 patients, 72 had follow-up data available. An increase in the degree of microhematuria was significantly associated with an eGFR decline of −0.81 mL/min/1.73 m2 [95% confidence interval (CI) −1.44 to −0.19, P = 0.01], after adjusting for follow-up time, proteinuria and T score. Severe microhematuria (≥21 RBCs/hpf) was associated with an even larger decline in eGFR (−3.99 mL/min/1.73 m2; 95% CI −6.9411 to −1.0552, P = 0.008), after similar adjustments. Conclusion Degree of microhematuria during follow-up is an independent predictor of eGFR decline after adjusting for clinical and histological parameters. Therefore, monitoring the degree of microhematuria as well as proteinuria is important when evaluating patients with IgAN. Additional studies using improvement in microhematuria as a primary surrogate outcome are needed. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

278. Plasma exchange for the management of ANCA-associated vasculitis: the con position.

Author

Specks, Ulrich, Fussner, Lynn A, Cartin-Ceba, Rodrigo, Moura, Marta Casal, Zand, Ladan, and Fervenza, Fernando C

Subjects
CHRONIC kidney failure, VASCULITIS, ANTINEUTROPHIL cytoplasmic antibodies, THERAPEUTICS, DIAGNOSIS
Abstract

Advances in the diagnosis and treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis have led to continued improvement in survival and prognosis over the course of the last 4 decades. Nevertheless, the most acute and severe disease manifestations, including severe kidney disease and alveolar hemorrhage, continue to be associated with increased early mortality from disease activity or treatment complications as well as risk for the development of end-stage kidney disease (ESKD), which in turn directly affects the overall prognosis of ANCA-associated vasculitis. Plasma exchange (PLEX) has long been proposed and used for these most severe disease manifestations under the assumption that its effects are swift and supported by our understanding of the pathogenic role of ANCA. Yet convincing evidence of a beneficial effect of PLEX in ANCA-associated vasculitis has been lacking, as early studies and small trials have generated conflicting results. The controversy regarding PLEX has been accentuated recently as the largest randomized controlled trial ever conducted in ANCA-associated vasculitis, the Plasma Exchange and Glucocorticoids in Severe ANCA-associated Vasculitis trial, which was specifically designed to evaluate the efficacy of PLEX in patients with severe renal disease or alveolar hemorrhage, failed to show a difference in the combined primary outcome measure of death or ESKD in patients who received PLEX versus those who did not. In light of these disappointing results, we herein review the currently available data on PLEX for ANCA-associated vasculitis and explain why we believe that these data no longer support the use of PLEX in ANCA-associated vasculitis. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

279. Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study.

Author

Erickson, Stephen B, Zand, Ladan, Nasr, Samih H, Alexander, Mariam P, Leung, Nelson, Drosou, Maria Eleni, and Fervenza, Fernando C

Subjects
MUSCLE cramps, RITUXIMAB, GLOMERULONEPHRITIS, KIDNEY physiology, PILOT projects, MUSCLE fatigue
Abstract

Background Fibrillary glomerulonephritis (FGN) is a rare type of glomerulonephritis with poor prognosis, with no known effective therapies available for treatment. The objective of the study was to evaluate the efficacy and safety of rituximab in treatment of patients with FGN and to investigate the effect of rituximab on DNAJB9 levels. Methods This was a pilot prospective clinical trial in which patients with idiopathic FGN were treated with two courses of rituximab (1 g each) 2 weeks apart at the beginning and then again at 6 months. Primary outcome was defined as preservation of kidney function at 12 months with stable or increased creatinine clearance. Secondary outcome was defined as achieving complete remission (CR) defined as proteinuria <300 mg/24 h or partial remission (PR) with proteinuria <3 g/24 h and at least 50% reduction in the proteinuria. DNAJB9 levels were also measured in the serum at baseline, 6 and 12 months. Results The creatinine clearance did not change significantly during this time, from 47.7 mL/min/1.73 m2 at baseline to 43.7 mL/min/1.73 m2 during follow-up (P = 0.15). Proteinuria declined from 4.43 (1.6–5.53) g/24 h at baseline to 1.9 (0.46–5.26) g/24 h at 12 months but did not reach significance (P = 0.06). None of the patients reached CR, and 3 of the 11 achieved PR. There was no change in the DNAJB9 levels following treatment with rituximab. The most common adverse event was nasal congestion, fatigue and muscle cramps. Conclusions Treatment of patients with two courses of rituximab over a span of 6 months was associated with stabilization of renal function but did not result in a significant change in proteinuria and with no change in the DNAJB9 levels. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

280. The association of serum calprotectin (S100A8/S100A9) levels with disease relapses in PR3-ANCA-associated vasculitis

Author

Pepper, Ruth J, Draibe, Juliana B, Caplin, Ben, Fervenza, Fernando C, Hoffman, Gary S, Kallenberg, Cees G.M, Langford, Carol A, Monach, Paul A, Seo, Philip, Spiera, Robert, St Clair, E. William, Tchao, Nadia K, Stone, John H, Specks, Ulrich, Merkel, Peter A, and Salama, AD

Subjects
Adult, Aged, 80 and over, Male, Adolescent, Myeloblastin, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Middle Aged, Severity of Illness Index, Article, Antibodies, Antineutrophil Cytoplasmic, Young Adult, Double-Blind Method, Predictive Value of Tests, Recurrence, Humans, Immunologic Factors, Female, Rituximab, Leukocyte L1 Antigen Complex, Biomarkers, Aged
Abstract

S100A8/A9 (calprotectin) has shown promise as a biomarker for predicting relapse in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). This study was undertaken to investigate serum S100A8/A9 level as a biomarker for predicting future relapse in a large cohort of patients with severe AAV.Serum levels of S100A8/A9 were measured at baseline and months 1, 2, and 6 following treatment initiation in 144 patients in the Rituximab in ANCA-Associated Vasculitis trial (cyclophosphamide/azathioprine versus rituximab [RTX] for induction of remission) in whom complete remission was attained.Patients were divided into 4 groups: proteinase 3 (PR3)-ANCA with relapse (n = 37), PR3-ANCA without relapse (n = 56), myeloperoxidase (MPO)-ANCA with relapse (n = 6), and MPO-ANCA without relapse (n = 45). Serum S100A8/A9 level decreased in all groups during the first 6 months of treatment. The percentage reduction from baseline to month 2 was significantly different between patients who experienced a relapse and those who did not in the PR3-ANCA group (P = 0.046). A significantly higher risk of relapse was associated with an increase in S100A8/A9 level between baseline and month 2 (P = 0.0043) and baseline and month 6 (P = 0.0029). Subgroup analysis demonstrated that patients treated with RTX who had increased levels of S100A8/A9 were at greatest risk of future relapse (P = 0.028).An increase in serum S100A8/A9 level by month 2 or 6 compared to baseline identifies a subgroup of PR3-ANCA patients treated with RTX who are at higher risk of relapse by 18 months. Since RTX is increasingly used for remission induction in PR3-ANCA-positive patients experiencing a relapse, S100A8/A9 level may assist in identifying those patients requiring more intensive or prolonged treatment.

Published
2017

281. Limited Significance of Antifactor H Antibodies in Patients with Membranous Nephropathy

Author

Sethi, Amit, Miao, Jing, Willrich, Maria Alice V., Frinack, Jody L., Cattran, Daniel C., Fervenza, Fernando C., Fervenza, Fernando C., Appel, Gerald B., Barbour, Sean J., Rovin, Brad H., Lafayette, Richard A., Aslam, Nabeel, Jefferson, Jonathan A., Gipson, Patrick E., Rizk, Dana V., Sedor, John R., Simon, James F., McCarthy, Ellen T., Brenchley, Paul, Sethi, Sanjeev, Avila-Casado, Carmen, Beanlands, Heather, Lieske, John C., Philibert, David, Li, Tingting, Thomas, Lesley F., Green, Dolly F., Juncos, Luis A., Beara-Lasic, Lada, Blumenthal, Samuel S., Sussman, Amy N., Erickson, Stephen B., Hladunewich, Michelle, Canetta, Pietro A., Hebert, Lee A., Leung, Nelson, Radhakrishnan, Jay, Reich, Heather N., Parikh, Samir V., Gipson, Debbie S., and Cattran, Daniel C.

Published
2021
Full Text
View/download PDF

282. The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study Network.

Author

Troost, Jonathan P, Waldo, Anne, Carlozzi, Noelle E, Murphy, Shannon, Modersitzki, Frank, Trachtman, Howard, Nachman, Patrick H, Reidy, Kimberly J, Selewski, David T, Herreshoff, Emily G, Srivastava, Tarak, Gibson, Keisha L, Derebail, Vimal K, Lin, Jen Jar, Hingorani, Sangeeta, Fornoni, Alessia, Fervenza, Fernando C, Sambandam, Kamalanathan, Athavale, Ambarish M, and Kopp, Jeffrey B

Subjects
FOCAL segmental glomerulosclerosis, NEPHROTIC syndrome, SYMPTOMS, EXPERIMENTAL design, SOCIAL anxiety, QUALITY of life
Abstract

Background Understanding the relationship between clinical and patient-reported outcomes (PROs) will help support clinical care and future clinical trial design of novel therapies for focal segmental glomerulosclerosis (FSGS). Methods FSGS patients ≥8 years of age enrolled in the Nephrotic Syndrome Study Network completed Patient-Reported Outcomes Measurement Information System PRO measures of health-related quality of life (HRQoL) (children: global health, mobility, fatigue, pain interference, depression, anxiety, stress and peer relationships; adults: physical functioning, fatigue, pain interference, sleep impairment, mental health, depression, anxiety and social satisfaction) at baseline and during longitudinal follow-up for a maximum of 5 years. Linear mixed-effects models were used to determine which demographic, clinical and laboratory features were associated with PROs for each of the eight children and eight adults studied. Results There were 45 children and 114 adult FSGS patients enrolled that had at least one PRO assessment and 519 patient visits. Multivariable analyses among children found that edema was associated with global health (−7.6 points, P = 0.02) and mobility (−4.2, P = 0.02), the number of reported symptoms was associated with worse depression (−2.7 per symptom, P = 0.009) and anxiety (−2.3, P = 0.02) and the number of emergency room (ER) visits in the prior 6 months was associated with worse mobility (−2.8 per visit, P < 0.001) and fatigue (−2.4, P = 0.03). Multivariable analyses among adults found the number of reported symptoms was associated with worse function in all eight PROMIS measures and the number of ER visits was associated with worse fatigue, pain interference, sleep impairment, depression, anxiety and social satisfaction. Laboratory markers of disease severity (i.e. proteinuria, estimated glomerular filtration rate and serum albumin) did not predict PRO in multivariable analyses, with the single exception of complete remission and better pain interference scores among children (+9.3, P  =  0.03). Conclusions PROs provide important information about HRQoL for persons with FSGS that is not captured solely by the examination of laboratory-based markers of disease. However, it is critical that instruments capture the patient experience and FSGS clinical trials may benefit from a disease-specific instrument more sensitive to within-patient changes. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

283. Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study

Author

Selewski, David T., primary, Ambruzs, Josephine M., additional, Appel, Gerald B., additional, Bomback, Andrew S., additional, Matar, Raed Bou, additional, Cai, Yi, additional, Cattran, Daniel C., additional, Chishti, Aftab S., additional, D'Agati, Vivette D., additional, D'Alessandri-Silva, Cynthia J., additional, Gbadegesin, Rasheed A., additional, Hogan, Jonathan J., additional, Iragorri, Sandra, additional, Jennette, J. Charles, additional, Julian, Bruce A., additional, Khalid, Myda, additional, Lafayette, Richard A., additional, Liapis, Helen, additional, Lugani, Francesca, additional, Mansfield, Sarah A., additional, Mason, Sherene, additional, Nachman, Patrick H., additional, Nast, Cynthia C., additional, Nester, Carla M., additional, Noone, Damien G., additional, Novak, Jan, additional, O'Shaughnessy, Michelle M., additional, Reich, Heather N., additional, Rheault, Michelle N., additional, Rizk, Dana V., additional, Saha, Manish K., additional, Sanghani, Neil S., additional, Sperati, C. John, additional, Sreedharan, Rajasree, additional, Srivastava, Tarak, additional, Swiatecka-Urban, Agnieszka, additional, Twombley, Katherine, additional, Vasylyeva, Tetyana L., additional, Weaver, Donald J., additional, Yin, Hong, additional, Zee, Jarcy, additional, Falk, Ronald J., additional, Gharavi, Ali G., additional, Gillespie, Brenda W., additional, Gipson, Debbie S., additional, Greenbaum, Larry A., additional, Holzman, Lawrence B., additional, Kretzler, Matthias, additional, Robinson, Bruce M., additional, Smoyer, William E., additional, Flessner, Michael, additional, Guay-Woodford, Lisa M., additional, Kiryluk, Krzysztof, additional, Gharavi, Ali, additional, Ahn, Wooin, additional, Avasare, Rupali S., additional, Babayev, Revekka, additional, Batal, Ibrahim, additional, Brown, Eric, additional, Campenot, Eric S., additional, Canetta, Pietro, additional, Chan, Brenda, additional, D’Agati, Vivette D., additional, Fernandez, Hilda, additional, Foroncewicz, Bartosz, additional, Ghiggeri, Gian Marco, additional, Hines, William H., additional, Jain, Namrata G., additional, Lin, Fangming, additional, Marasa, Maddalena, additional, Markowitz, Glen, additional, Mohan, Sumit, additional, Mucha, Krzysztof, additional, Nickolas, Thomas L., additional, Radhakrishnan, Jai, additional, Rao, Maya K., additional, Regunathan-Shenk, Renu, additional, Sanna-Cherchi, Simone, additional, Santoriello, Dominick, additional, Stokes, Michael B., additional, Yu, Natalie, additional, Valeri, Anthony M., additional, Zviti, Ronald, additional, Al-Uzri, Amira, additional, Ashoor, Isa, additional, Aviles, Diego, additional, Baracco, Rossana, additional, Barcia, John, additional, Bartosh, Sharon, additional, Belsha, Craig, additional, Braun, Michael C., additional, Chishti, Aftab, additional, Claes, Donna, additional, Cramer, Carl, additional, Davis, Keefe, additional, Erkan, Elif, additional, Feig, Daniel, additional, Freundlich, Michael, additional, Hanna, Melisha, additional, Hidalgo, Guillermo, additional, Jain, Amrish, additional, Kallash, Mahmoud, additional, Lane, Jerome C., additional, Mahan, John, additional, Mathews, Nisha, additional, Nester, Carla, additional, Pan, Cynthia, additional, Patel, Hiren, additional, Revell, Adelaide, additional, Steinke, Julia, additional, Wenderfer, Scott E., additional, Wong, Craig S., additional, Falk, Ronald, additional, Cook, William, additional, Derebail, Vimal, additional, Fogo, Agnes, additional, Gasim, Adil, additional, Gehr, Todd, additional, Harris, Raymond, additional, Kidd, Jason, additional, Laurin, Louis-Philippe, additional, Pendergraft, Will, additional, Pichette, Vincent, additional, Powell, Thomas Brian, additional, Renfrow, Matthew B., additional, Royal, Virginie, additional, Adler, Sharon, additional, Alpers, Charles, additional, Brown, Elizabeth, additional, Cattran, Daniel, additional, Choi, Michael, additional, Dell, Katherine M., additional, Dukkipati, Ram, additional, Fervenza, Fernando C., additional, Fornoni, Alessia, additional, Gadegbeku, Crystal, additional, Gipson, Patrick, additional, Hasely, Leah, additional, Hingorani, Sangeeta, additional, Hladunewich, Michelle A., additional, Hogan, Jonathan, additional, Jefferson, J. Ashley, additional, Jhaveri, Kenar, additional, Johnstone, Duncan B., additional, Kaskel, Frederick, additional, Kogan, Amy, additional, Kopp, Jeffrey, additional, Lemley, Kevin V., additional, Dieguez, Laura Malaga-, additional, Meyers, Kevin, additional, Neu, Alicia, additional, O’Shaughnessy, Michelle Marie, additional, O’Toole, John F., additional, Parekh, Rulan, additional, Reich, Heather, additional, Reidy, Kimberly, additional, Rondon, Helbert, additional, Sambandam, Kamalanathan K., additional, Sedor, John R., additional, Selewski, David T., additional, Sethna, Christine B., additional, Schelling, Jeffrey, additional, Swiatecka-Urban, Agnes, additional, Trachtman, Howard, additional, Tuttle, Katherine R., additional, Weisstuch, Joseph, additional, Zhdanova, Olga, additional, Gillespie, Brenda, additional, Barisoni, Laura, additional, Mansfield, Sarah, additional, Mariani, Laura, additional, and Wladkowski, Matthew, additional

Published
2018
Full Text
View/download PDF

286. Redefining Nephrotic Syndrome in Molecular Terms: Outcome-associated molecular clusters and patient stratification with noninvasive surrogate biomarkers

Author

Mariani, Laura H., primary, Eddy, Sean, additional, Martini, Sebastian, additional, Eichinger, Felix, additional, Godfrey, Brad, additional, Nair, Viji, additional, Adler, Sharon G., additional, Appel, Gerry B., additional, Athavale, Ambarish, additional, Barisoni, Laura, additional, Brown, Elizabeth, additional, Cattran, Dan C., additional, Dell, Katherine M., additional, Derebail, Vimal, additional, Fervenza, Fernando C., additional, Fornoni, Alessia, additional, Gadegbeku, Crystal A., additional, Gibson, Keisha L., additional, Gipson, Deb, additional, Greenbaum, Lawrence A., additional, Hingorani, Sangeeta R., additional, Hlandunewich, Michelle A., additional, Hogan, John, additional, Holzman, Larry B., additional, Jefferson, J. Ashley, additional, Kaskel, Frederick J., additional, Kopp, Jeffrey B., additional, Lafayette, Richard A., additional, Lemley, Kevin V., additional, Lieske, John C., additional, Lin, Jen-Jar, additional, Myers, Kevin E., additional, Nachman, Patrick H., additional, Nast, Cindy C., additional, Neu, Alicia M., additional, Reich, Heather N., additional, Sambandam, Kamal, additional, Sedor, John R., additional, Sethna, Christine B., additional, Srivastava, Tarak, additional, Trachtman, Howard, additional, Tran, Cheryl, additional, Wang, Chia-shi, additional, and Kretzler, Matthias, additional

Published
2018
Full Text
View/download PDF

287. Congophilic Fibrillary Glomerulonephritis: A Case Series

Author

Alexander, Mariam P., primary, Dasari, Surendra, additional, Vrana, Julie A., additional, Riopel, Julie, additional, Valeri, Anthony M., additional, Markowitz, Glen S., additional, Hever, Aviv, additional, Bijol, Vanesa, additional, Larsen, Christopher P., additional, Cornell, Lynn D., additional, Fidler, Mary E., additional, Said, Samar M., additional, Sethi, Sanjeev, additional, Herrera Hernandez, Loren Paola, additional, Grande, Joseph P., additional, Erickson, Stephen B., additional, Fervenza, Fernando C., additional, Leung, Nelson, additional, Kurtin, Paul J., additional, and Nasr, Samih H., additional

Published
2018
Full Text
View/download PDF

288. The impact of eculizumab on routine complement assays

Author

Willrich, Maria A.V., primary, Andreguetto, Bruna D., additional, Sridharan, Meera, additional, Fervenza, Fernando C., additional, Tostrud, Linda J., additional, Ladwig, Paula M., additional, Rivard, Ann M., additional, Hetrick, MeLea D., additional, Olson, Ryan N., additional, Bryant, Sandra C., additional, Snyder, Melissa R., additional, and Murray, David L., additional

Published
2018
Full Text
View/download PDF

289. The authors reply

Author

Ravindran, Aishwarya, primary, Fervenza, Fernando C., additional, Smith, Richard J.H., additional, and Sethi, Sanjeev, additional

Published
2018
Full Text
View/download PDF

292. Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort

Author

Berti, Alvise, primary, Cornec-Le Gall, Emilie, primary, Cornec, Divi, primary, Casal Moura, Marta, primary, Matteson, Eric L, primary, Crowson, Cynthia S, primary, Ravindran, Aishwarya, primary, Sethi, Sanjeev, primary, Fervenza, Fernando C, primary, and Specks, Ulrich, primary

Published
2018
Full Text
View/download PDF

293. Cryoglobulinaemia

Author

Roccatello, Dario, primary, Saadoun, David, additional, Ramos-Casals, Manuel, additional, Tzioufas, Athanasios G., additional, Fervenza, Fernando C., additional, Cacoub, Patrice, additional, Zignego, Anna Linda, additional, and Ferri, Clodoveo, additional

Published
2018
Full Text
View/download PDF

295. ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY: CONCLUSIONS FROM A «KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES» (KDIGO) CONTROVERSIES CONFERENCE

Author

H.J. Goodship, Timothy, primary, Cook, H. Terence, additional, Fakhouri, Fadi, additional, Fervenza, Fernando C., additional, Fremeaux-Bacchi, Veronique, additional, Kavanagh, David, additional, Nester, Carla M., additional, Noris, Marina, additional, Pickering, Matthew C., additional, De Co´rdoba, Santiago Rodrı´guez, additional, Roumenina, Lubka T., additional, Sethi, Sanjeev, additional, and J.H. Smith, Richard, additional

Published
2018
Full Text
View/download PDF

296. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft

Author

Said, Samar M., primary, Cosio, Fernando G., additional, Valeri, Anthony M., additional, Leung, Nelson, additional, Sethi, Sanjeev, additional, Salameh, Hassan, additional, Cornell, Lynn D., additional, Fidler, Mary E., additional, Alexander, Mariam P., additional, Fervenza, Fernando C., additional, Drosou, Maria Eleni, additional, Zhang, Da, additional, D’Agati, Vivette D., additional, and Nasr, Samih H., additional

Published
2018
Full Text
View/download PDF

298. Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders

Author

Higgins, Larissa, primary, Nasr, Samih H., additional, Said, Samar M., additional, Kapoor, Prashant, additional, Dingli, David, additional, King, Rebecca L., additional, Rajkumar, S. Vincent, additional, Kyle, Robert A., additional, Kourelis, Taxiarchis, additional, Gertz, Morie A., additional, Dispenzieri, Angela, additional, Lacy, Martha Q., additional, Buadi, Francis K., additional, Ansell, Stephen M., additional, Gonsalves, Wilson I., additional, Thompson, Carrie A., additional, Fervenza, Fernando C., additional, Zand, Ladan, additional, Hwa, Yi L., additional, Jevremovic, Dragan, additional, Shi, Min, additional, and Leung, Nelson, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results